Having trouble accessing articles? Reset your cache.

Emergent to acquire Trubion

Emergent BioSolutions Inc. (NYSE:EBS) will acquire Trubion Pharmaceuticals Inc. (NASDAQ:TRBN) in a cash and stock deal that the companies said values

Read the full 214 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE